Navigation Links
New drug strategy attacks resistant leukemia and lymphoma
Date:5/29/2012

o cause tumor cells to commit suicide in this fashion. But cancer cells can escape their death sentence and even become immortal by hyperactivating the survival arm of the family; these proteins intercept the executioner proteins and block their lethal mission.

"When cancers recur, they activate not just one type of survival protein, but many," explains Walensky, whose laboratory has extensively studied the cell-death system and makes compounds to manipulate it for research and therapeutic purposes.

"It's as if relapsed cancers 'learned' from their initial exposure to chemotherapy such that when they come back, they put up a variety of formidable barriers to apoptosis," he adds. "To reactivate cell death in refractory hematologic cancers, we need new pharmacologic strategies that broadly target these obstacles and substantially lower the apoptotic threshold."

When cancers specifically rely on one or two survival proteins, treating them with selective BCL-2 inhibitors can be very effective at eliminating the cancer cells' survival advantage. But relapsed cancers often evade such agents by deploying a battery of alternate survival proteins, so what's needed, Walensky says, are "next-generation" compounds that can block a wider range of survival proteins without jeopardizing normal tissues.

In the current research, the scientists built a chemically-reinforced peptide containing the death-activating BH3 domain of an especially potent killer protein, BIM, which is able to tightly bind with and neutralize all of the BCL-2 family survival proteins. This 'stapled' peptide, which incorporates the natural structure and properties of BIM BH3, not only disables the survival proteins, but also directly activates pro-death BCL-2 family proteins in cancer cells, making them self-destruct. Importantly, non-cancerous cells and tissues were relatively unaffected by the treatment.

"The diversity of BCL-2 family survival proteins blunts
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Strategy discovered to activate genes that suppress tumors and inhibit cancer
2. Discovery suggests new combination therapy strategy for basal-like breast cancers
3. White House Drug Policy Shifts Strategy
4. Scripps research scientists illuminate cancer cells survival strategy
5. Scientists report first step in strategy for cell replacement therapy in Parkinsons disease
6. Novel strategy stymies SARS et al.
7. UCSF tapped for US National AIDS Strategy initiative
8. Federal government releases environmental, health, and safety research strategy for nanotechnology
9. Miriam Hospital researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
10. Strategy for improving health care for uninsured, low-income, and minorities in the US
11. New strategy likely to speed drug development for rare cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New drug strategy attacks resistant leukemia and lymphoma
(Date:8/27/2014)... When it comes to the bedroom, most homeowners ... without breaking the bank in the process. Regardless of whether ... set for the master bedroom or simply looking for something ... all during their Labor Day mattress promotion. , This ... mattresses for the home, while enjoying free delivery. Beyond bringing ...
(Date:8/27/2014)... Taking its popular obstacle race to a new ... will host its largest crowd at its 3rd Annual ... YMCA Camp Thunderbird . , Hundreds of ... and teams. Within each division, runners will attempt to conquer ... for a worthy cause. All proceeds will fund scholarships ...
(Date:8/27/2014)... August 28, 2014 All Canada Goose ... they can go from classic to modern. With unique detailing ... each of them is a step up in opulence. Recently, ... Goose Banff Parkas for 2014. , True enough, ... now offering great discounts (up to 28% off) on all ...
(Date:8/27/2014)... The New York Mobility Club (sponsored by ... about “ Sexuality & Intimacy ” for people with ... entertaining discussions are for mature audiences only. September 9 ... Mamaroneck, NY) and October 7 from 6-8 pm at ... The New York Mobility Club is a local community ...
(Date:8/27/2014)... 2014 Recently, iFitDress.com, a professional company ... new designs of romantic bridal gowns . To ... promotional price (up to 66 percent off) when buying ... product line has been updated with these new items. ... iFitDress.com hopes that all clients can gain an enjoyable ...
Breaking Medicine News(10 mins):Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2
... , CINCINNATI, Dec. 8, ... PG ) today announced the appointment of Angela ... WellPoint, Inc. (NYSE: WLP ), to its ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091208/CL22979-a ) ...
... is open for the 2010 AIUM Annual Convention and ... United States dedicated to all disciplines of medical ultrasound, ... California. The 2010 Annual Convention focuses on emerging applications ... and manufacturers as ultrasound continues to advance and expand ...
... 7, 2009Scientists at The Scripps Research Institute have determined the ... though rare, is one of the deadliest viruses on the ... Described in the advance, online Early Edition of the journal ... PNAS ), the research reveals how a key component of ...
... say , TUESDAY, Dec. 8 (HealthDay News) -- The human ... study shows how the twisting and turning differs between men ... published in the Dec. 8 online edition of Circulation: ... different heartbeats they saw in 29 men and 29 women, ...
... Over two-thirds of study patients benefited from high-flow oxygen ... High-flow oxygen appears to be an effective treatment for ... cluster headaches can have as many as eight per ... The current treatment is injection with the drug sumatriptan, ...
... male sex hormone causes status-seeking behavior, but not aggression, ... People associate testosterone with aggressiveness, but the male sex ... new study finds. , Testosterone does not cause aggression, ... economics at Royal Holloway, University of London. But it ...
Cached Medicine News:Health News:Procter & Gamble Announces Appointment of Director 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Scripps Research scientists reveal key structure from ebola virus 2Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new ... Global Orthopedic Soft Tissue Repair Devices ... About Orthopedic Soft Tissue Repair ... cells that connect, support, or surround bones. There ... as tendons, ligaments, cartilage, fascia, and other fibrous ...
(Date:8/27/2014)... LOS ANGELES , Aug. 27, 2014   ... , now offers AcceleDent® Aura to patients who want ... to orthodontic care available at the OrthoSpaceship, all patients ... healthier, better-looking teeth. This system can be used by ... boost their rate of progress by using the AcceleDent® ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... Several abstracts highlighting CIMZIA,s long-term benefits and value ... American College,of Gastroenterology (ACG), ORLANDO, Fla. Oct. ... by UCB at the American College of Gastroenterology,(ACG) ... the,only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) ...
... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announced ... Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran ... was presented at the,American College of Gastroenterology (ACG) ... provided data from a preclinical study of,RDEA119, the ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4
... laparoscopic procedures, the Advantage Smart Table goes ... tables but is versatile enough to accommodate ... remote, this table remembers positions for various ... multi-articulation or return to level. The simple ...
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
Inquire...
...
Medicine Products: